OMA1 and lymphoma: More specifically, BTM pyrazolo-thiazoles (BTM-3528 and BTM-3566) selectively kill lymphoma cells by allosterically turning on OMA1, which then cleaves its two key substrates, OPA1 and DELE1, to couple mitochondrial dynamics to the ISR and intrinsic apoptosis.